An informative article discusses the US BIOSECURE Act and its effects on China’s CDMO industry. It highlights that Indian CDMO companies are set to gain, noting a substantial rise in interest and site visits from major pharmaceutical and biotech firms in India. It may take 2 to 3 years to play out this theme, but surely it will.
CDMO industry post BIOSECURE Act: who will take WuXi’s place?.
| Subscribe To Our Free Newsletter |
